Xenon Pharmaceuticals
XENE
#3579
Rank
A$4.67 B
Marketcap
$61.29
Share price
1.17%
Change (1 day)
33.86%
Change (1 year)

Xenon Pharmaceuticals (XENE) - Cash on Hand

Cash on Hand as of June 2024 : A$1.11 Billion

According to Xenon Pharmaceuticals's latest financial reports the company has A$1.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Xenon Pharmaceuticals - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.93 B7.64%
2022-12-31A$0.87 B14.32%
2021-12-31A$0.76 B230.64%
2020-12-31A$0.23 B14.01%
2019-12-31A$0.20 B19.22%
2018-12-31A$0.16 B202.78%
2017-12-31A$55.93 M-37.15%
2016-12-31A$88.98 M10.53%
2015-12-31A$80.51 M-21.6%
2014-12-31A$0.10 B85.89%
2013-12-31A$55.24 M-4.58%
2012-12-31A$57.89 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.15 B-86.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.34 M-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA